Ninety day adverse events following single level posterior lumbar interbody fusion in patients with sickle cell disease
Dhodapkar M, Halperin S, Saifi C, Whang P, Grauer J, Varthi A. Ninety day adverse events following single level posterior lumbar interbody fusion in patients with sickle cell disease. The Spine Journal 2023, 24: 807-811. PMID: 38081460, DOI: 10.1016/j.spinee.2023.11.025.Peer-Reviewed Original ResearchPosterior lumbar interbody fusionSingle-level posterior lumbar interbody fusionSickle cell diseaseElixhauser Comorbidity IndexAdverse eventsPostoperative outcomesInterbody fusionOdds ratioCell diseaseDays adverse eventsMinor adverse eventsPostoperative adverse eventsPerioperative adverse eventsSevere adverse eventsCohort of patientsED visit ratesEmergency department visitsMultivariable logistic regressionNational administrative databaseRetrospective database studyLumbar interbody fusionSingle level posteriorComorbidity indexPLIF patientsAdult patientsEvolving Trends in the Use of Sacroiliac Fusion From 2015 to 2020
Halperin S, Dhodapkar M, Jiang W, Elaydi A, Jordan Y, Whang P, Grauer J. Evolving Trends in the Use of Sacroiliac Fusion From 2015 to 2020. Spine 2023, 49: 577-582. PMID: 37075329, DOI: 10.1097/brs.0000000000004684.Peer-Reviewed Original ResearchSI fusionOpen approachAdverse eventsSacroiliac fusionHigher Elixhauser comorbidity indexRetrospective cohort analysisElixhauser Comorbidity IndexLess adverse eventsEvolution of patientsComorbidity indexAdult patientsPatient characteristicsPrimary outcomeIndependent predictorsPearlDiver databaseMultivariable analysisPatient populationOpen procedureBACKGROUND DATACohort analysisSI jointDegenerative indicationsMIS approachMIS casesOlder age